Ásgeir R. Helgason

Waning sexual function - The most important disease-specific distress for patients with prostate cancer

The objective was to investigate how prostate cancer and its treatment affects sexual, urinary and bowel functions and to what extent eventual complications cause distress. A questionnaire was sent to 431 men aged 50-80 years with prostate cancer diagnosed in 1992 in the Stockholm area (Sweden) and 435 randomly selected men with a similar age distribution. Sexual function, as compared with their youth, was diminished in a majority of all men. The prostate cancer patients were, however, more likely to report low frequency and/or intensity in all aspects of sexual function. A majority of the men were distressed by a waning sexual capacity. The proportion of men with prostate cancer who were severely distressed owing to a decline in sexual function was larger than in the reference group. The willingness to trade off an intact sexual function for long-term survival varied considerably among the men in the reference group. Urinary and bowel symptoms were less common than a waning sexual function in both groups, and few appeared to be severely distressed by urinary or bowel symptoms. A decline in sexual functions was the most common cause of disease-specific distress in men with prostate cancer.

Awareness of husband's impending death from cancer and long-term anxiety in widowhood: a nationwide follow-up

Background: We investigated the predictors and long-term consequences of awareness time — the length of time a woman is aware of her husbands impending death from cancer. Methods: All women (n / 506) living in Sweden under 80 years of age who lost their husband/partner owing to cancer of the prostate in 1996 or of the urinary bladder in 1995 or 1996 were followed with an anonymous postal questionnaire, 2–4 years after their loss. Results: We received completed questionnaires from 379 of the widows. Of these, 55 (15%) reported an awareness time of 24 hours or less, 56 (15%) of 3–6 months and 95 (26%) of one year or more. The associations between the awareness time and morbidity were of a reverted ‘J-shape,’ with awareness time of 24 hours or less carrying the highest risk and 3–6/6–12 months the lowest. On comparing the awareness time of 24 hours or less with 3–6 months (preformed response category), the relative risks for anxiety were found to be 1.9 (1.0–3.6) (visual digital scale) and 4.5 (1.0–20.0) for intake of tranquillising drugs. Those not informed of their husbands fatal condition or not provided with psychological support by caregivers during their husbands last months of life had an increased risk of a short awareness time. Conclusions: During a mans terminal cancer illness, the wifes awareness time varies considerably and is influenced by information and psychological support from caregivers. A short awareness time may result in an additional and avoidable psychological trauma.

Factors Associated With Waning Sexual Function Among Elderly Men and Prostate Cancer Patients

PURPOSE We identified factors that affect sexual function in men 50 to 80 years old and, therefore, may confound the comparison among groups of elderly men. In particular, we identified factors that may influence a comparison between prostate cancer patients and the general population, or confound the relationship when comparing subgroups of patients in nonrandomized studies. MATERIALS AND METHODS A questionnaire, including the Radiumhemmet Scale of Sexual Function and modules assessing potential risk factors for waning sexual function, was sent to 431 patients 50 to 80 years old with prostate cancer diagnosed 1.5 to 2 years previously in the Stockholm area (Sweden) and a reference group of 435 age matched randomly selected men. RESULTS Factors associated with physiological impotence included prostate cancer (relative risk 1.9), diabetes mellitus (relative risk 2.3), myocardial infarction (relative risk 1.5), medication with diuretics (relative risk 1.5), hydrogen blockers (relative risk 2.3) and warfarin type anticoagulants (relative risk 1.7). Patients treated for prostate cancer were more likely to be physiologically impotent compared to those with no initial treatment, and this was true for all treatment protocols after adjustment for confounding factors. Men treated with radical prostatectomy were more likely to be physiologically impotent than men treated with external beam radiation therapy (relative risk 1.5). CONCLUSIONS Waning sexual function in the prostate cancer patients was largely due to side effects of the treatment and this could not be explained by confounding factors. In particular, confounding could not explain the greater risk of impotence after radical prostatectomy compared to external beam radiation therapy.

Emotional isolation: prevalence and the effect on well-being among 50-80-year-old prostate cancer patients.

Objective: To investigate to what extent prostate cancer patients confide their emotional concerns, and whether having no one to confide in affects well-being. Material and methods: A population-based study using epidemiological methods. A questionnaire was mailed to all 431 living prostate cancer patients aged 50-80 at the time of selection, diagnosed 1.5-2 years previously in Stockholm County, and 435 randomly selected men in the same age group. The questionnaire was completed anonymously. The main outcome measures included questions assessing the extent to which the men could share emotionally taxing feelings with their partner or others and questions assessing well-being. Results: The questionnaire was returned by 79% of the patients and by 73% of the randomly selected men. Approximately one in five patients had no one to confide in. Of patients living with a partner, only one in 10 confided in someone other than their partner. Three out of 10 patients living in a relationship could not confide in their partner. Men having no one to confide in were less content with their life and reported poorer psychological and overall well-being compared with other men. The prostate cancer patients were not more likely to have someone to confide in than men in general. Conclusions: The results indicate that a lack of emotional support may be a problem for many prostate cancer patients and that the traditional psychosocial support offered to most cancer patients in Sweden may not reach male patients. There may be a need for a gender-adapted approach to emotional support.OBJECTIVE To investigate to what extent prostate cancer patients confide their emotional concerns, and whether having no one to confide in affects well-being. MATERIAL AND METHODS A population-based study using epidemiological methods. A questionnaire was mailed to all 431 living prostate cancer patients aged 50-80 at the time of selection, diagnosed 1.5-2 years previously in Stockholm County, and 435 randomly selected men in the same age group. The questionnaire was completed anonymously. The main outcome measures included questions assessing the extent to which the men could share emotionally taxing feelings with their partner or others and questions assessing well-being. RESULTS The questionnaire was returned by 79% of the patients and by 73% of the randomly selected men. Approximately one in five patients had no one to confide in. Of patients living with a partner, only one in 10 confided in someone other than their partner. Three out of 10 patients living in a relationship could not confide in their partner. Men having no one to confide in were less content with their life and reported poorer psychological and overall well-being compared with other men. The prostate cancer patients were not more likely to have someone to confide in than men in general. CONCLUSIONS The results indicate that a lack of emotional support may be a problem for many prostate cancer patients and that the traditional psychosocial support offered to most cancer patients in Sweden may not reach male patients. There may be a need for a gender-adapted approach to emotional support.

A Test of the Validity of the Motivational Interviewing Treatment Integrity Code

To evaluate the Swedish version of the Motivational Interviewing Treatment Code (MITI), MITI coding was applied to tape‐recorded counseling sessions. Construct validity was assessed using factor analysis on 120 MITI‐coded sessions. Discriminant validity was assessed by comparing MITI coding of motivational interviewing (MI) sessions with information‐ and advice‐giving sessions as well as by comparing MI‐trained practitioners with untrained practitioners. A principal‐axis factoring analysis yielded some evidence for MITI construct validity. MITI differentiated between practitioners with different levels of MI training as well as between MI practitioners and advice‐giving counselors, thus supporting discriminant validity. MITI may be used as a training tool together with supervision to confirm and enhance MI practice in clinical settings. MITI can also serve as a tool for evaluating MI integrity in clinical research.

To what extent do parents strive to protect their children from environmental tobacco smoke in the Nordic countries? A population-based study

OBJECTIVE To assess to what extent Nordic parents strive to protect their children from environmental tobacco smoke (ETS) at home. DESIGN A cross-sectional study using an anonymous questionnaire. SUBJECTS AND SETTING A stratified, random sample of 5500 households containing a child born during 1992, including 1500 households in Denmark and 1000 households in each of the countries of Finland, Iceland, Norway, and Sweden. MAIN OUTCOME MEASURES Smoking status of parents, prevalence and magnitude of weekly ETS exposure, rules regarding smoking in the home. RESULTS 82% of current smokers reported having tried to change their smoking behaviour for the sake of their children. Of all parents who answered the questionnaire, 75% reported having introduced some rules to limit ETS in their home. In households where at least one parent smoked, 57% reported that children were exposed to ETS at home. Child exposure to ETS was most prevalent in single-parent households and in households in which parents had lower levels of education. However, these parents were not less likely than other smoking parents to report having tried to change their smoking behaviour for the sake of their children. CONCLUSION Environmental tobacco smoke at home is still a problem for many children in the Nordic countries. However, most smoking parents reported having made efforts to change their smoking behaviour for the sake of their children; and in approximately half of all households containing at least one daily smoker, parents reported protecting their children from ETS exposure in the home. Although actual exposure may be higher owing to possible under-reporting of ETS, our results indicate a general awareness in the Nordic countries of the potential negative effects of ETS on children.

Dose-Response Relations for Anal Sphincter Regarding Fecal Leakage and Blood or Phlegm in Stools after Radiotherapy for Prostate Cancer

Background:The estimation of the parameters that describe the dose-response relations of anal sphincter regarding the clinical endpoints of fecal leakage and blood or phlegm in stools is important in the optimization of prostate cancer radiotherapy. Also, the validity of the relative seriality model for this clinical case needs to be examined by associating the clinical follow-up results with the predicted complication rates.Patients and Methods:In this study, 65 patients who received radiation therapy for clinically localized prostate adenocarcinoma are analyzed. The clinical treatment outcome and the three-dimensional dose distribution delivered to anal sphincter were available for each patient. A questionnaire was used for assessing the clinical bowel and urinary symptoms. A maximum likelihood fitting was performed to calculate the best estimates of the parameters used by the relative seriality model. The clinical utilization of the calculated parameters in predicting anal sphincter complication probabilities was illustrated by applying the best estimate of the parameters to a subset of the patient population.Results:The estimated values of the parameters for the two clinical endpoints are D50 = 70.2 Gy, γ = 1.22, s = 0.35 for fecal leakage and D50 = 74.0 Gy, γ = 0.75, s ≈ 0 for blood or phlegm in stools. The standard deviations of the parameters were also calculated together with the confidence intervals of the dose-response curves. The analysis proved that the treatment outcome pattern of the patient material can suitably be reproduced by the relative seriality model (probability of finding a worse fit = 60.2%, the area under the receiver operating characteristic curve = 0.72 and 0.69 and χ2-test = 0.97 and 0.86, respectively).Conclusion:Fecal leakage is characterized by a medium relative seriality whereas blood or phlegm in stools was found to have strong volume dependence (low relative seriality). Diminishing the biologically effective uniform dose to anal sphincter < 40–45 Gy may significantly reduce the risk of fecal leakage or blood or phlegm in stools for patients irradiated for prostate cancer.Hintergrund:Um die Strahlenbehandlung des Prostatakarzinoms optimieren zu können, ist ein Modell der Dosis-Wirkungs-Beziehung für die Analsphinkterfunktion notwendig, dessen Parameter verlässlich geschätzt werden können. Es sollte die klinischen Endpunkte Stuhlinkontinenz und Blut oder Schleim im Stuhl beschreiben. Zusätzlich sollte die Gültigkeit des Relative-Seriality-Modells überprüft werden, indem die Befunde des klinischen Follow-up mit den prognostizierten Komplikationsraten verglichen werden.Patienten und Methodik:Diese Studie umfasst 65 Patienten, die wegen eines klinisch manifesten lokalisierten Adenokarzinoms der Prostata eine Strahlenbehandlung erhalten hatten. Das klinische Ergebnis und die Dosisverteilung im Analsphinkter waren für jeden Patienten verfügbar. Klinische Symptome des Darms und der Harnwege wurden mittels eines Fragebogens erfasst. Die Parameter des Relative-Seriality-Modells wurden mit Hilfe der Maximum-Likelihood-Methode bestimmt. Bei einer Untergruppe der Patienten wurden die besten Schätzwerte der Parameter angewendet. Der klinische Nutzen für die Prognose von Komplikationen des Analsphinkters konnte dargestellt werden.Ergebnisse:Die Schätzwerte der Parameter der zwei klinischen Endpunkte sind D50 = 70,2 Gy, γ = 1,22, s = 0,35 für Stuhlinkontinenz und D50 = 74,0 Gy, γ = 0,75, s ≈ 0 für Blut oder Schleim im Stuhl. Die Standardabweichungen der Parameter wurden ebenso berechnet wie die Konfidenzintervalle. Die Analyse (untersucht wurden: Probability of Finding worse Fit = 60,2%, die Fläche unter ROC-Kurven 0,72 bzw. 0,69 und χ2 = 0,97 und 0,86) beweist, dass das Behandlungsergebnis bei den untersuchten Patienten mit Hilfe des Relative-Seriality-Modells gut wiedergegeben wird.Schlussfolgerungen:Die Stuhlinkontinenz zeigt eine mittlere Relative Seriality, während für Blut oder Schleim im Stuhl eine starke Volumenabhängigkeit gefunden wurde (geringe Relative Seriality). Eine Reduktion der biologisch effektiven, uniformen Dosis des Analsphinkters unter 40-45 Gy könnte die Risiken der Stuhlinkontinenz und von Blut oder Schleim im Stuhl für Prostatakarzinom-Patienten signifikant senken.

Quitline in smoking cessation: A cost-effectiveness analysis

OBJECTIVES The cost-effectiveness of the Swedish quitline, a nation-wide, free of charge service, is assessed. METHODS The study was based on data of a sample of 1131 callers enrolled from February 1, 2000 to November 30, 2001. Outcome was measured as cost per quitter and cost per year of life saved. Cost per quitter was based on a calculation of the total cost of the quitline divided by the number of individuals who reported abstinence after 12 months. The cost per life year saved (LYS) was calculated by the use of data from the literature on average life expectancy for smokers versus quitters, the total cost of the quitline, and the cost of pharmacological treatment. RESULTS The number of smokers who used the quitline and reported abstinence after 1 year was 354 (31 percent). The accumulated number of life years saved in the study population was 2400. The cost per quitter was 1052-1360 USD, and the cost per life year saved was 311-401 USD. A sensitivity analysis showed that, for outcomes down to an abstinence rate of 20 percent, the cost per LYS rose modestly, from 311 to 482 USD. Discounting the cost per LYS showed the cost to be 135 USD for 3 percent and 283 USD for 5 percent. CONCLUSIONS The Swedish quitline is a cost-effective public health intervention compared with other smoking cessation interventions.

Dose-Response Relations for Anal Sphincter Regarding Fecal Leakage and Blood or Phlegm in Stools after Radiotherapy for Prostate Cancer Radiobiological Study of 65 Consecutive Patients

Background:The estimation of the parameters that describe the dose-response relations of anal sphincter regarding the clinical endpoints of fecal leakage and blood or phlegm in stools is important in the optimization of prostate cancer radiotherapy. Also, the validity of the relative seriality model for this clinical case needs to be examined by associating the clinical follow-up results with the predicted complication rates.Patients and Methods:In this study, 65 patients who received radiation therapy for clinically localized prostate adenocarcinoma are analyzed. The clinical treatment outcome and the three-dimensional dose distribution delivered to anal sphincter were available for each patient. A questionnaire was used for assessing the clinical bowel and urinary symptoms. A maximum likelihood fitting was performed to calculate the best estimates of the parameters used by the relative seriality model. The clinical utilization of the calculated parameters in predicting anal sphincter complication probabilities was illustrated by applying the best estimate of the parameters to a subset of the patient population.Results:The estimated values of the parameters for the two clinical endpoints are D50 = 70.2 Gy, γ = 1.22, s = 0.35 for fecal leakage and D50 = 74.0 Gy, γ = 0.75, s ≈ 0 for blood or phlegm in stools. The standard deviations of the parameters were also calculated together with the confidence intervals of the dose-response curves. The analysis proved that the treatment outcome pattern of the patient material can suitably be reproduced by the relative seriality model (probability of finding a worse fit = 60.2%, the area under the receiver operating characteristic curve = 0.72 and 0.69 and χ2-test = 0.97 and 0.86, respectively).Conclusion:Fecal leakage is characterized by a medium relative seriality whereas blood or phlegm in stools was found to have strong volume dependence (low relative seriality). Diminishing the biologically effective uniform dose to anal sphincter < 40–45 Gy may significantly reduce the risk of fecal leakage or blood or phlegm in stools for patients irradiated for prostate cancer.Hintergrund:Um die Strahlenbehandlung des Prostatakarzinoms optimieren zu können, ist ein Modell der Dosis-Wirkungs-Beziehung für die Analsphinkterfunktion notwendig, dessen Parameter verlässlich geschätzt werden können. Es sollte die klinischen Endpunkte Stuhlinkontinenz und Blut oder Schleim im Stuhl beschreiben. Zusätzlich sollte die Gültigkeit des Relative-Seriality-Modells überprüft werden, indem die Befunde des klinischen Follow-up mit den prognostizierten Komplikationsraten verglichen werden.Patienten und Methodik:Diese Studie umfasst 65 Patienten, die wegen eines klinisch manifesten lokalisierten Adenokarzinoms der Prostata eine Strahlenbehandlung erhalten hatten. Das klinische Ergebnis und die Dosisverteilung im Analsphinkter waren für jeden Patienten verfügbar. Klinische Symptome des Darms und der Harnwege wurden mittels eines Fragebogens erfasst. Die Parameter des Relative-Seriality-Modells wurden mit Hilfe der Maximum-Likelihood-Methode bestimmt. Bei einer Untergruppe der Patienten wurden die besten Schätzwerte der Parameter angewendet. Der klinische Nutzen für die Prognose von Komplikationen des Analsphinkters konnte dargestellt werden.Ergebnisse:Die Schätzwerte der Parameter der zwei klinischen Endpunkte sind D50 = 70,2 Gy, γ = 1,22, s = 0,35 für Stuhlinkontinenz und D50 = 74,0 Gy, γ = 0,75, s ≈ 0 für Blut oder Schleim im Stuhl. Die Standardabweichungen der Parameter wurden ebenso berechnet wie die Konfidenzintervalle. Die Analyse (untersucht wurden: Probability of Finding worse Fit = 60,2%, die Fläche unter ROC-Kurven 0,72 bzw. 0,69 und χ2 = 0,97 und 0,86) beweist, dass das Behandlungsergebnis bei den untersuchten Patienten mit Hilfe des Relative-Seriality-Modells gut wiedergegeben wird.Schlussfolgerungen:Die Stuhlinkontinenz zeigt eine mittlere Relative Seriality, während für Blut oder Schleim im Stuhl eine starke Volumenabhängigkeit gefunden wurde (geringe Relative Seriality). Eine Reduktion der biologisch effektiven, uniformen Dosis des Analsphinkters unter 40-45 Gy könnte die Risiken der Stuhlinkontinenz und von Blut oder Schleim im Stuhl für Prostatakarzinom-Patienten signifikant senken.

Long-term effects of widowhood after terminal cancer: a Swedish nationwide follow-up

Aims: The authors investigated whether becoming a widow after the death of a husband from cancer results in long-term psychological or physical morbidity. Method: In April and May 1999, an attempt was made to contact all of the 506 women who were living with men dying of prostate cancer in 1996 or of urinary bladder cancer in 1995 or 1996, as well as 287 population controls. Results: Completed questionnaires were received from 379 of the widows and 220 of the controls. Widowhood was associated with a low or moderate subjective quality of life (relative risk [RR]=1.4, 95% confidence interval 1.2—1.7), low or moderate psychological well-being (RR=1.8, 1.4—2.3), anxiety (RR=1.9, 1.3—2.7), depression (RR=2.2, 1.6—2.9), sleep disturbances (RR=1.9, 1.5—2.4), diabetes (RR=3.5, 1.2—7.9), and economic dissatisfaction (RR=1.6, 1.3—2.0). Conclusion: An excess risk of psychological morbidity, diabetes mellitus and dissatisfaction with the economic situation was found in the widowed population.